Back to Search
Start Over
The First Report of Two Cases of Fatal Liver Injury Due to Anti-tuberculosis Drugs in the Presence of Alpha-1 Antitrypsin Deficiency.
- Source :
- International Journal of Mycobacteriology; Apr-Jun2017, Vol. 6 Issue 2, p187-190, 4p
- Publication Year :
- 2017
-
Abstract
- Tuberculosis (TB) is a major global health problem. Awareness of liver injury due to anti-TB therapy is vital because fulminant hepatic failure is a devastating and often fatal condition without liver transplantation. Here, we report for the first time, two patients of fatal liver injury due to anti-TB drugs in the presence of alpha-1 antitrypsin deficiency. Based on the triad of rapid loss in hepatocyte function, the onset of hepatic encephalopathy, and absence of a prior history of liver disease, the diagnosis of acute liver failure was established. Both patients had low levels of serum alpha-1 antitrypsin, consistent with alpha-1 antitrypsin deficiency. Despite aggressive medical therapy and supportive care, patients developed multi-organ failure and died. It seems measuring the serum levels of alpha 1-antitrypsin before beginning anti-TB therapies is necessary, especially when there is emphysema or bronchiectasis. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 22125531
- Volume :
- 6
- Issue :
- 2
- Database :
- Complementary Index
- Journal :
- International Journal of Mycobacteriology
- Publication Type :
- Academic Journal
- Accession number :
- 123322428
- Full Text :
- https://doi.org/10.4103/ijmy.ijmy_60_17